Market Cap 16.36M
Revenue (ttm) 0.00
Net Income (ttm) -24.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -2.88
Volume 604,700
Avg Vol 794,818
Day's Range N/A - N/A
Shares Out 53.29M
Stochastic %K 35%
Beta 2.87
Analysts Strong Sell
Price Target $5.50

Company Profile

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel...

Industry: Biotechnology
Sector: Healthcare
Phone: 353 1 903 8354
Address:
3 Dublin Landings, North Wall Quay, Dublin, Ireland
Alder77
Alder77 Feb. 3 at 3:50 PM
$ITRM What does Shionogi say he's about to buy? Listen to the DollerADay ‘s bullshit 🤣🤣🤣🤡🤡🤡. Buy today or tomorrow?
0 · Reply
Steloco1
Steloco1 Feb. 3 at 3:42 PM
$ITRM After we shut his teller machine down he'll find funds no doubt. He'll sell soon to get his seed money back. His lack of communication is typical of a Bean counter . He's the CEO because it's his company. A Proper CEO knows how to sell his product. Obviously he doesn't.
1 · Reply
Alder77
Alder77 Feb. 3 at 3:29 PM
$ITRM Anyone who votes YES or doesn't vote is complicit in this scam. This pile of shit must be stopped, and with it that idiot Fishman.
0 · Reply
dnangel
dnangel Feb. 3 at 3:10 PM
$ITRM Hard NO on further dilution. 50M new shares for $5–10M runway while top management takes ~$3M/year? Reduce exec pay. Protect shareholders. Show accountability. We’re being asked to fund another year with little upside. $ITRM
0 · Reply
dnangel
dnangel Feb. 3 at 3:10 PM
$ITRM Shareholders shouldn’t fund dilution while exec comp stays sky-high. Asking for 50M more shares to maybe raise $5–10M, while leadership pulls ~$3M/year? Cut salaries first. Align with shareholders. Then talk dilution. The math doesn’t math. $ITRM
1 · Reply
dnangel
dnangel Feb. 3 at 2:47 PM
$ITRM We should not vote in fever of further dilution. Either Fishman, Judy communication make his yearly compensation to 150k or nake it reasonable. Fishman idiot want more 50 million share which might raise max 5 to 10 million $ while 3 idiots at ITRM getting paid almost 3 million year.
1 · Reply
StonkZombie
StonkZombie Feb. 3 at 2:29 PM
$ITRM If they don't announce an earnings report date this week, by Friday, then it won't be happening next week, and therefore won't be happening before the Extraordinary General Meeting. Translation: they have absolutely nothing good to report and want to beg for money. Bums beg for money.
1 · Reply
Schindelegger
Schindelegger Feb. 3 at 2:19 PM
$ITRM And please stop the ‘Silence Period’ fairytales. This piece of shit has been silent for years and since I bought in.
1 · Reply
Schindelegger
Schindelegger Feb. 3 at 2:10 PM
$ITRM Earnings no earlier than 2/17?! 🤦🏻‍♂️ Oh my if this is true and God forbid it is after 2/18 there are literally no positives to share.
1 · Reply
YakoCapital
YakoCapital Feb. 3 at 1:50 PM
$ITRM Corey, make some phone calls to your buddies
1 · Reply
Latest News on ITRM
Iterum Therapeutics Provides Business Update

Dec 23, 2025, 8:00 AM EST - 6 weeks ago

Iterum Therapeutics Provides Business Update


Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript

Nov 14, 2025, 11:11 AM EST - 2 months ago

Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript


Iterum Therapeutics Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 7:00 AM EST - 2 months ago

Iterum Therapeutics Reports Third Quarter 2025 Financial Results


Iterum Therapeutics to Present Data at IDWeek 2025

Oct 14, 2025, 8:30 AM EDT - 4 months ago

Iterum Therapeutics to Present Data at IDWeek 2025


Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:58 PM EDT - 6 months ago

Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript


Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript

May 13, 2025, 1:44 PM EDT - 9 months ago

Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript


Iterum Therapeutics Reports First Quarter 2025 Financial Results

May 13, 2025, 7:00 AM EDT - 9 months ago

Iterum Therapeutics Reports First Quarter 2025 Financial Results


Iterum Therapeutics Regains Full Nasdaq Compliance

Nov 21, 2024, 8:30 AM EST - 1 year ago

Iterum Therapeutics Regains Full Nasdaq Compliance


US FDA approves Iterum's treatment for urinary infection

Oct 25, 2024, 10:57 AM EDT - 1 year ago

US FDA approves Iterum's treatment for urinary infection


Iterum Therapeutics to Present Data at IDWeek 2024

Oct 10, 2024, 8:30 AM EDT - 1 year ago

Iterum Therapeutics to Present Data at IDWeek 2024


Iterum Therapeutics plc (ITRM) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 11:27 AM EDT - 1 year ago

Iterum Therapeutics plc (ITRM) Q2 2024 Earnings Call Transcript


Iterum Therapeutics Commences Rights Offering

Jul 22, 2024, 7:30 AM EDT - 1 year ago

Iterum Therapeutics Commences Rights Offering


Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 10:08 AM EDT - 2 years ago

Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript


Alder77
Alder77 Feb. 3 at 3:50 PM
$ITRM What does Shionogi say he's about to buy? Listen to the DollerADay ‘s bullshit 🤣🤣🤣🤡🤡🤡. Buy today or tomorrow?
0 · Reply
Steloco1
Steloco1 Feb. 3 at 3:42 PM
$ITRM After we shut his teller machine down he'll find funds no doubt. He'll sell soon to get his seed money back. His lack of communication is typical of a Bean counter . He's the CEO because it's his company. A Proper CEO knows how to sell his product. Obviously he doesn't.
1 · Reply
Alder77
Alder77 Feb. 3 at 3:29 PM
$ITRM Anyone who votes YES or doesn't vote is complicit in this scam. This pile of shit must be stopped, and with it that idiot Fishman.
0 · Reply
dnangel
dnangel Feb. 3 at 3:10 PM
$ITRM Hard NO on further dilution. 50M new shares for $5–10M runway while top management takes ~$3M/year? Reduce exec pay. Protect shareholders. Show accountability. We’re being asked to fund another year with little upside. $ITRM
0 · Reply
dnangel
dnangel Feb. 3 at 3:10 PM
$ITRM Shareholders shouldn’t fund dilution while exec comp stays sky-high. Asking for 50M more shares to maybe raise $5–10M, while leadership pulls ~$3M/year? Cut salaries first. Align with shareholders. Then talk dilution. The math doesn’t math. $ITRM
1 · Reply
dnangel
dnangel Feb. 3 at 2:47 PM
$ITRM We should not vote in fever of further dilution. Either Fishman, Judy communication make his yearly compensation to 150k or nake it reasonable. Fishman idiot want more 50 million share which might raise max 5 to 10 million $ while 3 idiots at ITRM getting paid almost 3 million year.
1 · Reply
StonkZombie
StonkZombie Feb. 3 at 2:29 PM
$ITRM If they don't announce an earnings report date this week, by Friday, then it won't be happening next week, and therefore won't be happening before the Extraordinary General Meeting. Translation: they have absolutely nothing good to report and want to beg for money. Bums beg for money.
1 · Reply
Schindelegger
Schindelegger Feb. 3 at 2:19 PM
$ITRM And please stop the ‘Silence Period’ fairytales. This piece of shit has been silent for years and since I bought in.
1 · Reply
Schindelegger
Schindelegger Feb. 3 at 2:10 PM
$ITRM Earnings no earlier than 2/17?! 🤦🏻‍♂️ Oh my if this is true and God forbid it is after 2/18 there are literally no positives to share.
1 · Reply
YakoCapital
YakoCapital Feb. 3 at 1:50 PM
$ITRM Corey, make some phone calls to your buddies
1 · Reply
Alder77
Alder77 Feb. 3 at 1:29 PM
$ITRM And the scam continues. Go DollerADay, tell some of your bullshit…😂🤣
0 · Reply
Twills08
Twills08 Feb. 3 at 12:59 PM
$CAPT $HYFT $ITRM $NVO $RAIN CAPT: as predicted, gold is continuing its rise after a brief retrace. In the face of a weakening dollar, cryptocurrencies’ nascent, bear market, and threats of war, this could easily be one of the largest movers of the year. Currently mid $0.50’s. If 10:1 acquisition of the Montana Tunnel mines, we are looking at $4-5. Mineral assessment is pending, and it could be released any day. This will be key in determining the price target. Acquisition is set to be completed by the end of the first quarter. NASDAQ approved an extension based upon this pending acquisition with a deadline of March 31. I suspect we will hear something very very soon. HYFT: Just hit the reload zone. The chart is primed for rebound. They released groundbreaking news on an influenza vaccine breakthrough, and I suspect that they have an investor pool building up as we speak. I am looking for $4 per share, and it’s currently at $1.60.  ITRM: Flared almost 20% yesterday on low volume. There is not much liquidity left, and I am hopeful for a PBM update, as well as some sort of shining light at the end of the tunnel for this small bio pharmaceutical based out of Ireland. They have one of the only oral penem antibiotics approved by FDA, but have been constrained by a consistent lack of capital. Big Pharma is going to have a vested interest in picking up this company as cheap as possible, but we haven’t seen much in the way of share price movement to date. It looks good for a jump back to $.60 in my opinion. Currently at low $0.30s. NVO: earnings will be released on the fourth, and I am very bullish on this one. They had a full month of their newly FDA approved oral GLP-1 to add to the tally, and with 18,000 scripts in the first week of it’s release, I suspect a price target of $70 is reasonable. Currently trading at $58.88. RAIN: Oversold. Way oversold. No liquidity. Rapid correction incoming on this small startup with a solid financial foundation. I like this one for $8-9 per share, but earnings may send it up further. I suspect big things are coming here. Above all, DD and decide for yourself. NFA, as I’m not God’s gift to anything. GLTY.
1 · Reply
gandolf63
gandolf63 Feb. 3 at 12:56 PM
$ITRM after thinking about this for a while, I don’t think there is a buyout on the table. It doesn’t make sense to beg for a shareholders vote with in the works. To me what’s imperative is getting that extension by NASDAQ. Somehow he has to give them a plan how to go forward to for compliance. That’s the number one goal. Then he can if he hasn’t already begun to look for a licensing deal or partnership. Fish will have to set his goal to get paid back maybe a couple years while he can continue to get the drug out and to show big Pharma that it can be a success. Pfizer is the most logical one to do a licensing deal with to me, but who knows .
1 · Reply
StonkZombie
StonkZombie Feb. 3 at 11:10 AM
$ITRM So, what's on the agenda for today? No news, share price stuck interminably in the low .30's, zero shareholder communication from the management and all the while Corey Fishman earns at least $480/hour without even coming into the office as he asks you for the authorization to keep printing shares and maybe do a reverse split so this useless scam can continue on the NASDAQ for the foreseeable future. Did I miss anything?
1 · Reply
Curvanord12
Curvanord12 Feb. 3 at 9:12 AM
$ITRM the answer would be: it’s been one year that something is going on behind the scenes. In the meantime, we lost 80% since February 2025.
1 · Reply
XJCX
XJCX Feb. 3 at 9:00 AM
$ITRM If someone asked, ‘Is something going on behind the scenes?’, the honest answer would be: yes, most likely.
1 · Reply
Amb8675309
Amb8675309 Feb. 3 at 6:07 AM
$ITRM @gandolf63, and I was running these conspiracy theories from stock twits by him and he was laughing at the idea that Christine Coyne’s salary was being withheld because she secretly worked for INVA(forgot who came up with that one). He thought the whole thing was funny and I’m sitting there thinking, “this whole thing is going on because you’re not communicating”. He found it amusing and I’m thinking there’s a clear connection between what you say or don’t say and the stories people create in an information VACUUM😳 I think we’ll have a better chance of figuring out who built the Giza pyramids/are there aliens already on planet earth/who killed Epstein, than what the hell went on with the lowball offers, the PIPE, the 10 month gap between the PDUFA and the launch, the PZE IOU extension- so many unnecessary information gaps🤔
1 · Reply
Amb8675309
Amb8675309 Feb. 3 at 5:55 AM
$ITRM OK cooled down. I’m going to wait till the very last minute to vote. There’s nothing he has said to any of us( recently) that would make someone vote yes. I’m sure we’re all shaking our heads, thinking, “Did he not understand how we felt the last time we voted NO?” I think dollar a day may be on to something-hopefully there’s some sort of deal going on that at least gets us NASDAQ compliant and one step closer to some sort of BO we can all be happy with. No one can be that foolish to ask us twice(without any honest explanation), in such a short period of time, right? 🤦‍♀️There’s a lot of really great forensic investment work that’s been done on this thread. Many of us have been here over a year, trying to figure out what’s going on. What’s so sad is that timely PRs by someone with skill could have saved us all a bunch of time(&💰) and also built good will- bet the share price would have been higher too.
2 · Reply
DollerADay
DollerADay Feb. 3 at 4:12 AM
$ITRM If Shionogi the announcement comes next Monday, perfectly solving the 10 day compliance. It’s horse shit Iterum can sit on the FDA response for two weeks despite the 4 day rule because of a buyout. Hoping some retail sells and I can steal them quicker than the tutes shadow loading the past four days. Silence the remainder of the week leaves one option and one outcome alone. Giddy up. FYI on Shionogi’s bizarre silence this month
1 · Reply
WhereistheSEC
WhereistheSEC Feb. 3 at 3:39 AM
$ITRM As far as which way one will/should vote, one should be ready to change their mind up ti the last minute, when they actually cast their vote(or decide not to.) The fact is things could change at any moment. We should be constantly evaluating the situation, as having a closed mind is dangerous. I would say many Trump voters believe he has deeper ties to Epstein than previously thought, but imagine a ”smoking gun” proving criminal ”misconduct “ involving underage trafficked girls had come out the day before the election. Would that have changed the outcome? perhaps that is a poor example. It probably would have had no effect…
1 · Reply
Biorocksme
Biorocksme Feb. 3 at 1:02 AM
$ITRM Hey Mr Corey FIshman, call your largest shareholder and do some explaining. Be a CEO, be a man.
0 · Reply
WhereistheSEC
WhereistheSEC Feb. 3 at 1:00 AM
$ITRM everything was going swimmingly. I make one comment about Silver and it drops 30% in a day. I don’t have delusions of grandeur but it does feel like I am being watched sometimes.
2 · Reply